000			03968cam a22004458i 4500
001			9780429242717
003			FlBoTFG
005			20220509192915.0
006			m o d
007			cr cnu---unuuu
008			190723s2020 onc ob 001 0 eng
040			_aOCoLC-P _beng _erda _cOCoLC-P
020			_a9780429242717 _q(PDF)
020			_a0429242719
020			_a9780429512469 _q(electronic bk. : PDF)
020			_a0429512465 _q(electronic bk. : PDF)
020			_a9780429519321 _q(electronic bk. : Mobipocket)
020			_a042951932X _q(electronic bk. : Mobipocket)
020			_a9780429515897 _q(electronic bk. : EPUB)
020			_a0429515898 _q(electronic bk. : EPUB)
020			_z9781771887977 _q(hardcover)
035			_a(OCoLC)1109936077
035			_a(OCoLC-P)1109936077
050	0	0	_aRM315
072		7	_aSCI _x089000 _2bisacsh
072		7	_aMMG _2bicssc
082	0		_a615.7/8 _223
245	0	0	_aAdvances in neuropharmacology : _bdrugs and therapeutics / _cedited by Md. Sahab Uddin, Mamunur Rashid.
264		1	_aOakville, ON, Canada ; _aPalm Bay, Florida, USA : _bApple Academic Press, _c2020.
300			_a1 online resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
520			_a"This new volume, Advances in Neuropharmacology: Drugs and Therapeutics, provides a comprehensive overview of the drugs that act on the central and peripheral nervous systems. It thoroughly describes the diseases that are associated with the nervous system and drugs used their treatment while also looking at the current status of these drugs and their future potential and challenges. This book is divided into three sections that describe the nervous system associated diseases and their treatment as well as current status and future opportunities and challenges. Section 1 focuses on the drugs that affect the functions of the autonomic nervous system to produce therapeutic effects. These drugs may act presynaptically by manipulating the genesis, storage, and secretion, and by blocking the action of neurotransmitters. Some drugs may trigger or impede postsynaptic receptors. Section 2 focuses on drugs that affect the central nervous system, including antianxiety drugs, sedative and hypnotic drugs, antidepressant drugs, antipsychotic drugs, antiepileptic drugs, and many more. It covers the pharmacological management of various diseases, including Alzheimer's, Parkinson's, Huntington's disease, and others. Section 3 offers explanations of neurochemical interactions with the aim to develop drugs that have beneficial effects on neurochemical imbalances. This section demonstrates models to assess the transport of drugs across the blood-brain barrier and nanomedicine to treat brain disorders. This rich compilation provides thorough and extensive research updates on the important advances in neuropharmacological drugs and drug therapy from experienced and eminent academicians, researchers, and scientists from throughout the world. It will be rich resource for professionals, academicians, students, researchers, scientists, and industry professionals around the world in the biomedical, health, and life science fields. Key features: Presents recent advances in neuropharmacology, covering the drugs that act on the central and peripheral nervous systems; Provides extensive explanations of various emerging research in this field; Explores the intricacy of neurological disorders Looks at existing and forthcoming therapeutic drug strategies"-- _cProvided by publisher.
588			_aOCLC-licensed vendor bibliographic record.
650		0	_aNeuropharmacology.
700	1		_aSahab Uddin, Md., _d1992- _eeditor.
700	1		_aRashid, Mamunur _c(Professor of pharmacology), _eeditor.
856	4	0	_3Taylor & Francis _uhttps://www.taylorfrancis.com/books/9780429242717
856	4	2	_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
999			_c126273 _d126273